Molecular classification and application of glioma based on cdc20 gene co-expression network
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- BEIJING NORMAL UNIVERSITY
- Publication Date
- 2021-02-05
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of biotechnology, in particular to a molecular classification and application of glioma based on CDC20 gene co-expression network. Background technique
[0002] Glioblastoma (GBM) is the most common primary malignant tumor of the central nervous system in adults, accounting for more than 50%. Although there have been many studies to explore the causes of glioblastoma and feasible treatment options, the survival period of patients with glioblastoma is still very short, with a median survival period of less than two years. Glioblastoma is in a continuous evolutionary process with complex cytological and genetic heterogeneity. The genome of glioblastoma contains many single nucleotide variations and is also characterized by chromosomal instability (CIN). Studies have found that glioblastoma cells have a high frequency of abnormal chromosome number events (non- euploid) and chromosomal structural variation events. Thes...